- $1.52bn
- $1.78bn
- $443.64m
Brief: Alkami Announces Second Quarter 2024 Financial Results
Brief: Alkami Technology Q2 Revenue USD 82.16 Million Vs. IBES Estimate USD 81.4 Million
Alkami Technology Inc expected to post earnings of 3 cents a share - Earnings Preview
Brief: Alkami Technology On July 1 Entered Into A Second Amendment To Co's Amended And Restated Credit Agreement Dated As Of April 29, 2022
Brief: Alkami Technology Q1 Revenue USD 76.127 Million Vs. IBES Estimate USD 75.5 Million
Alkami Technology Inc expected to post earnings of 2 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Okta, Salesforce, Sarepta Therapeutics
Alkami Technology Inc reports results for the quarter ended in December - Earnings Summary
Brief: Alkami Technology Q4 Revenue USD 71.369 Million Vs. IBES Estimate USD 71.1 Million
Alkami Technology Inc expected to post earnings of 2 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Air Products and Chemicals, Assurant, Celanese
U.S. RESEARCH ROUNDUP-Arthur J. Gallagher & Co., Costco Wholesale, Idexx Laboratories
Alkami Technology Inc reports results for the quarter ended in September - Earnings Summary
Brief: Alkami Technology Q3 Revenue USD 67.703 Million Vs. IBES Estimate USD 67.2 Million
Brief: Alkami Partners With Atomic To Offer Direct Deposit Solution For Financial Institutions
U.S. RESEARCH ROUNDUP-Apellis Pharmaceuticals, CDW, Equinix
Alkami Technology Inc reports results for the quarter ended in June - Earnings Summary
Brief: Alkami Technology Q2 Revenue USD 65.763 Million Vs. IBES Estimate USD 63.1 Million
Alkami Technology Inc expected to post a loss of 5 cents a share - Earnings Preview